[1] WANG Y, WANG Z, YUE ZH, et al.Risk assessment of pesticide residues in domestic ginsengs[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2019, 44(7):1327-1333. [2] ZUO TT, ZHANG L, SHI SM, et al.Risk assessment and theoretical limits for heavy metals and harmful elements in 10 types of root and rhizome Chinese medicinal materials[J]. Chinese Journal of Pharmaceutical Analysis(药物分析杂志), 2020, 40(10):1870-1876. [3] FAN YY, WANG CH, JIANG QD.Overview of aflatoxin B1 contamination in traditional Chinese medicine[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(10):608-616,622. [4] DUAN SM, KONG M, ZHANG YB, et al.Correlation between sulfur dioxide residue and quality change of sulfur-fumigated Angelica Sinensis Radix[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2016, 22(21):41-44. [5] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China, Volume Ⅳ(中华人民共和国药典四部)[M]. Beijing: China Medical Science Press, 2020: 29-31. [6] LIU QT, KONG WJ, YANG MH, et al.Review of scientific preservation techniques for traditional Chinese medicine becoming mouldy during storage[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2015, 40(7):1223-1229. [7] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China, Volume Ⅳ(中华人民共和国药典四部)[M]. Beijing: China Medical Science Press, 2020: 275-279, 236, 280, 239. [8] LI HB, LI MY, ZHAO D, et al.Oral bioavailability of As, Pb, and Cd in contaminated soils, dust, and foods based on animal bioassays: A review[J]. Environmental Scicence & Technology, 2019, 53(18): 10545-10559. [9] MIAO DR, LI X, YANG WQ.Health risk assessment of Cu, Pb, Zn, Cd, Cr and As in tea leaves from Fengqing County in Yunnan[J]. Journal of Kunming University(昆明大学学报), 2019, 41(3): 56-60. [10] ZUO TT, WANG Y, ZHANG L, et al.Guideline of risk assessment of exogenous harmful residues in traditional Chinese medicines[J]. Chinese Journal of Pharmaceutical Analysis(药物分析杂志), 2019, 39(10): 1902-1907. [11] WANG YBN, LIU AD, LI JW, et al.The survey of traditional Chinese medicine consumption among adult residents in 11 provinces and cities[J]. Chinese Pharmaceutical Affairs(中国药事), 2017, 31(6): 666-672. [12] WANG YBN, JIN HY, ZHANG L.The situation investigation of traditional Chinese medicine adult consumers in 11 provinces of China[J]. Journal of Yunnan University of Traditional Chinese Medicine(云南中医学院学报), 2017, 40(2): 71-75. [13] MAO WF, WANG YBN, ZUO TT, et al.Risk assessment of lead exposure of Chinese medicinal herbs in Chinese population[J]. Drug Standards of China(中国药品标准), 2018, 19(4): 275-281. [14] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China, Volume I(中华人民共和国药典一部)[M]. Beijing: China Medical Science Press, 2020: 215. [15] U.S.Environmental Protection Agency. IRIS Summaries Chromium (VI) (CASRN 1854002909) [R]. Washington DC: U.S. Environmental Protection Agency, 1998. [16] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China, Volume Ⅳ(中华人民共和国药典四部)[M]. Beijing: China Medical Science Press, 2020: 520-522. [17] WANG YH, AN Y, ZHANG M, et al.Analysis and health risk assessment of sulfur dioxide residue in Ginseng roots[J]. Food Science(中国中药杂志), 2015,36(24):214-219. |